Centre Léonard de Vinci
- Address
- Route de Cambrai, 59187 Dechy, France
Centre Léonard de Vinci - Colorectal Cancer Research
Centre Léonard de Vinci is actively engaged in advanced oncological research, with a particular focus on innovative treatment strategies for gastrointestinal malignancies. The center participates in cutting-edge clinical trials investigating circulating tumor DNA (ctDNA) as a biomarker for treatment decision-making in colorectal cancer patients.
- Post-surgical surveillance and adjuvant therapy optimization in high-risk colorectal cancer
- Circulating tumor DNA monitoring for minimal residual disease detection
- Advanced chemotherapy combinations with targeted biological agents in stage II and III colon carcinoma
The center's research portfolio emphasizes precision oncology approaches, utilizing molecular biomarkers to guide therapeutic interventions. Their participation in multicentric trials evaluating novel chemotherapy regimens, including FOLFIRI with bevacizumab and trifluridine-tipiracil combinations, demonstrates their commitment to improving outcomes for patients with colorectal cancer through personalized treatment strategies based on ctDNA surveillance.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 28 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Léonard de Vinci
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| De-escalation of endocrine therapy in postmenopausal women with low-risk HR+ HER2- low Luminal A early breast cancer: a single-arm study of omission versus combination therapy | Unicancer | Phase II | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 28 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 3 | Unknown | 2024-09-24 | 2026-05-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.